NRP1 and melanoma: Next, we analysed the cytotoxic activity of CD8+ TIL toward autologous melanoma cells in the absence or presence of neutralising anti-Nrp-1 and/or anti-PD-1 mAb, with an isotype-matched mAb as negative control.